Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines

ClinicalTrials.gov ID: NCT03004248

Public ClinicalTrials.gov record NCT03004248. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multi-Center Trial to Assess the Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines (SAKURA OPEN-LABEL SAFETY)

Study identification

NCT ID
NCT03004248
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Revance Therapeutics, Inc.
Industry
Enrollment
2,691 participants

Conditions and interventions

Interventions

  • Botulinum Toxins, Type A Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 8, 2016
Primary completion
Oct 16, 2018
Completion
Oct 16, 2018
Last update posted
Jul 12, 2022

2016 – 2018

United States locations

U.S. sites
56
U.S. states
21
U.S. cities
47
Facility City State ZIP Site status
Not listed Birmingham Alabama 35205
Not listed Beverly Hills California 90210
Not listed Encinitas California 92024
Not listed Fremont California 94538
Not listed Los Angeles California 90069
Not listed Manhattan Beach California 90266
Not listed Newport Beach California 92663
Not listed Roseville California 95661
Not listed Sacramento California 95819
Not listed San Diego California 92121
Not listed San Diego California 92122
Not listed San Francisco California 94117
Not listed Santa Monica California 90404
Not listed Greenwood Village Colorado 80111
Not listed Washington D.C. District of Columbia 20007
Not listed Washington D.C. District of Columbia 20037
Not listed Boca Raton Florida 33431
Not listed Bradenton Florida 34209
Not listed Coral Gables Florida 33146
Not listed Miami Florida 33137
Not listed West Palm Beach Florida 33401
Not listed Chicago Illinois 60611
Not listed Lincolnshire Illinois 60069
Not listed Naperville Illinois 60563
Not listed New Orleans Louisiana 70124
Not listed New Orleans Louisiana 70130
Not listed Baltimore Maryland 21208
Not listed Glenn Dale Maryland 20769
Not listed Hunt Valley Maryland 21030
Not listed Rockville Maryland 20850
Not listed Chestnut Hill Massachusetts 27517
Not listed Birmingham Michigan 48009
Not listed Fridley Minnesota 55432
Not listed St Louis Missouri 63122
Not listed Omaha Nebraska 68144
Not listed Montclair New Jersey 07042
Not listed New York New York 10011
Not listed New York New York 10016
Not listed New York New York 10022
Not listed New York New York 10028
Not listed New York New York 10029
Not listed New York New York 10075
Not listed West Islip New York 11795
Not listed White Plains New York 10604
Not listed Chapel Hill North Carolina 27517
Not listed Charlotte North Carolina 28207
Not listed High Point North Carolina 27262
Not listed Portland Oregon 97223
Not listed Drexel Hill Pennsylvania 19026
Not listed Nashville Tennessee 37203
Not listed Nashville Tennessee 37215
Not listed Austin Texas 78746
Not listed College Station Texas 77845
Not listed Houston Texas 77056
Not listed Katy Texas 77494
Not listed Mequon Wisconsin 53092

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03004248, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03004248 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →